Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation.
about
Insulin-like growth factor binding proteins: a structural perspective.Dysregulated expression of growth factors and their receptors in the development of prostate cancer.Growth factors and their receptors in prostate cancer.IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells.Differential expression of IGF components and insulin receptor isoforms in human seminoma versus normal testicular tissueEndoglin regulates cancer-stromal cell interactions in prostate tumorsTemporal expression patterns of insulin-like growth factor binding protein-4 in the embryonic and postnatal rat brain.Insulin-like growth factor binding protein-4 differentially inhibits growth factor-induced angiogenesis.mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.Interaction of AIM with insulin-like growth factor-binding protein-4.Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancerAssessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patientsExpression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer.Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient miceOverexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression.Insulin- like Growth Factor-Binding Protein Action in Bone Tissue: A Key Role for Pregnancy- Associated Plasma Protein-A.
P2860
Q30417447-99F840AD-7A1A-4DBA-8260-C2655D7E5F83Q33807246-16DCC43A-AAE7-432B-BE5E-7FC1D269A819Q34539272-B24370AB-F6AF-453B-85F4-B621143E76BAQ34740473-4AA1D3C5-8B87-4F7B-A644-E161299F577BQ34768464-DCD88E41-FFDE-4CC6-A037-3DD326094C0EQ34988080-287753B4-1039-4E6C-BAE4-B5BB41D9B22DQ35029480-8023E19C-124C-4F45-BB21-1E031DBE342FQ35693958-C9587CF7-82E2-4ED2-AC1D-ABAD7067B4F1Q35921941-1EA6F6DB-02FA-4391-ABC5-0D4171C051D9Q35944697-A3B356B5-0C74-48BB-9F37-21DAF0988C71Q36298306-0CD52991-6FA3-4107-9803-B3AB99090F04Q37064715-8A33AACF-DCEA-447A-8B30-4AE4A968E483Q37287447-5798C1DB-B176-423A-BC37-FB2549162F4DQ37418923-132D9B49-DD46-4A1C-B0DA-07872F513C08Q39740877-4EF28523-014B-4098-B4CC-2790290A233FQ42363910-22B52663-569C-4E1E-8918-8BDB8F556237Q52728979-270E5A5C-64EC-4645-9498-BCCFCC3E5305
P2860
Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Overexpression of an inhibitor ...... t of prostate tumor formation.
@en
type
label
Overexpression of an inhibitor ...... t of prostate tumor formation.
@en
prefLabel
Overexpression of an inhibitor ...... t of prostate tumor formation.
@en
P2093
P356
P1433
P1476
Overexpression of an inhibitor ...... t of prostate tumor formation.
@en
P2093
P304
P356
10.1210/ENDO.139.8.6150
P407
P577
1998-08-01T00:00:00Z